Westfield Capital Management
CRL icon

Westfield Capital Management’s Charles River Laboratories CRL Stock Holding History

Westfield Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-262,657
Closed -$76.1M – 246
2021
Q1 		$76.1M Sell
262,657
-30,969
-11% -$8.61M 0.47% 74
2020
Q4 		$73.4M Buy
293,626
+24,264
+9% +$5.78M 0.44% 82
2020
Q3 		$61M Sell
269,362
-32,248
-11% -$6.69M 0.39% 84
2020
Q2 		$52.6M Buy
301,610
+80,000
+36% +$12.8M 0.36% 94
2020
Q1 		$28M Sell
221,610
-5,046
-2% -$757K 0.25% 122
2019
Q4 		$34.6M Buy
226,656
+6,998
+3% +$969K 0.25% 129
2019
Q3 		$29.1M Buy
219,658
+37,479
+21% +$5.03M 0.23% 126
2019
Q2 		$25.9M Sell
182,179
-48,963
-21% -$6.64M 0.19% 153
2019
Q1 		$33.6M Sell
231,142
-3,535
-2% -$464K 0.26% 129
2018
Q4 		$26.6M Buy
+234,677
New +$29.4M 0.23% 133

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Westfield Capital Management's CRL Position: Q2 2021 in Review

Westfield Capital Management sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 262,657 shares — an estimated $76.1M sold.

Westfield Capital Management first reported a position in CRL in Q4 2018 and held it in 10 quarters. The position peaked at $76.1M in Q1 2021. 638 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • Westfield Capital Management reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
  • Westfield Capital Management sold 262,657 Charles River Laboratories shares in Q2 2021, an estimated $76.1M.
  • Westfield Capital Management first reported a position in Charles River Laboratories in Q4 2018 and held it in 10 quarters.
  • Westfield Capital Management's Charles River Laboratories position peaked at $76.1M in Q1 2021.
  • 638 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Westfield Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.